Completed PHASE1 INTERVENTIONAL 3-arm
NCT06699355
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
A Clinical Study to Evaluate the Effect of MK-0616 and Atorvastatin on Their Respective Pharmacokinetics in Healthy Adult Participants
Sponsor: Merck Sharp & Dohme LLC
Conditions
Healthy
Interventions
Atorvastatin Enlicitide Decanoate
Updated 1 time since 2024 Last updated: Nov 19, 2024 Started: Nov 8, 2023 Primary completion: Dec 29, 2023 Completion: Dec 29, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Merck Sharp & Dohme LLC and has accumulated 1 data snapshot since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Merck Sharp & Dohme LLC
Data source: Merck Sharp & Dohme LLC
For direct contact, visit the study record on ClinicalTrials.gov .